The human gut harbors a diverse and dynamic microbial ecosystem, with members of the genus Bifidobacterium playing crucial roles in modulating host health. Among them, Bifidobacterium animalis subsp. lactis has emerged as one of the most studied and commercially applied species in probiotic research. Owing to its robust survivability, immunomodulatory properties, and favorable safety profile, this microorganism has become an essential component in next-generation probiotics (NGPs). As global demand increases for functionally validated probiotic strains, B. animalis subsp. lactis continues to draw attention from both academic and industrial researchers. Creative Biolabs is at the forefront of probiotic innovation, offering advanced solutions for the characterization, optimization, and application of B. animalis subsp. lactis in microbiome-targeted research.
B. animalis subsp. lactis is a subspecies of B. animalis, which belongs to the phylum Actinobacteria, family Bifidobacteriaceae. It is a Gram-positive, non-motile, anaerobic bacterium known for its high tolerance to acidic and bile environments. Initially grouped under B. bifidum, it was later reclassified based on 16S rRNA and hsp60 gene analyses, distinguishing subsp. lactis from its close relative subsp. animalis.
Level | Classification |
---|---|
Domain | Bacteria |
Phylum | Actinobacteria |
Class | Actinobacteria |
Order | Bifidobacteriales |
Family | Bifidobacteriaceae |
Genus | Bifidobacterium |
Species | B. animalis |
Subspecies | B. animalis subsp. lactis |
Variants such as B. animalis subsp. lactis BB-12, HN019, 420, and 700541 have been extensively documented in both in vitro and human studies. These strains are widely incorporated into dairy products, dietary supplements, and investigational microbiome studies due to their proven stability and functionality.
Fig.1 Potential mechanisms how Bifidobacterium lactis HN019 may modulate colonic motility in humans.2
Numerous clinical and preclinical studies have demonstrated the efficacy of B. animalis subsp. lactis in modulating intestinal homeostasis, strengthening epithelial barrier integrity, and supporting metabolic balance. BB-12, for instance, enhances short-chain fatty acid (SCFA) production, especially acetate, which contributes to a favorable gut environment and pathogen suppression.
B. animalis subsp. lactis influences both innate and adaptive immunity by enhancing secretory IgA levels, regulating cytokine expression (e.g., IL-10, IL-6, IFN-γ), and interacting with intestinal epithelial receptors. These properties make it highly relevant in immune modulation studies.
Under anaerobic fermentation, this strain maintains high viability, bile salt resistance, and acid tolerance. These attributes support its use in robust microencapsulation and delivery systems designed for colonic release in probiotic applications.
With the rising interest in individualized nutrition, B. animalis subsp. lactis is frequently selected for inclusion in personalized probiotic blends, due to its consistency in colonization and host compatibility across diverse populations.
Get a quote Now →
As a keystone member of the gut ecosystem, B. animalis subsp. lactis helps restore microbiota composition following disruptions due to antibiotics, stress, or dietary changes. It fosters a favorable microbiome by competitively excluding harmful microbes and promoting commensal growth.
It modulates mucosal immunity by interacting with toll-like receptors and promoting the release of regulatory cytokines, contributing to improved intestinal and systemic immune balance in controlled experimental systems.
While not for clinical application, studies show B. animalis subsp. lactis has been explored in relation to conditions such as IBD, IBS, and obesity in research settings. These studies report improvements in inflammation markers, gut permeability, and microbial balance.
Its compatibility with prebiotics like inulin and FOS (fructooligosaccharides) allows the creation of synbiotic formulations that show enhanced probiotic viability and host benefit in microbiome research models.
B. animalis subsp. lactis is GRAS-certified by the FDA and recognized by EFSA for qualified presumption of safety. It has been consumed safely in a variety of products for decades, under regulatory frameworks that assess microbial strains used in food and research.
Genomic analysis of key strains shows absence of mobile antibiotic resistance genes and virulence factors. Its genetic makeup is stable, with no evidence of horizontal gene transfer, making it suitable for rigorous live biotherapeutic development pipelines.
Extensive toxicological and safety assessments in rodent models and healthy human subjects have shown no adverse effects, translocation, or toxicity. Its safety profile is one of the reasons for its widespread use in academic and commercial research.
Creative Biolabs employs precision anaerobic culturing and selective media to isolate high-purity B. animalis subsp. lactis strains from diverse sources. Each isolate undergoes initial genotypic and phenotypic screening to ensure strain identity, genetic stability, and desired probiotic traits for downstream development.
Isolated strains are assessed for functional capabilities such as SCFA production, bile salt hydrolase activity, and mucosal adhesion. Mechanistic assays including immune cell co-culture and epithelial barrier models help elucidate interactions with host pathways, supporting scientific validation of probiotic potential.
Our team optimizes anaerobic fermentation parameters—such as pH, oxygen tension, and media composition—to maximize viable biomass yield and metabolite activity. Process parameters are tailored to maintain viability and key functional attributes of B. animalis subsp. lactis for scale-up readiness.
We offer controlled lab-scale manufacturing, including fermentation, concentration, and freeze-drying. Each batch is validated for colony-forming unit (CFU) counts, strain purity, and activity retention, ensuring reliable supply for preclinical studies, formulation trials, and regulatory submission.
B. animalis subsp. lactis is a scientifically validated and widely utilized strain in probiotic research, recognized for its robust gastrointestinal survivability, functional versatility, and well-documented safety. Its roles in gut microbiota balance, immune regulation, and synbiotic synergy make it a cornerstone of next-generation probiotic innovation. As research continues to evolve toward personalized and precision microbiome interventions, the strategic integration of B. animalis subsp. lactis becomes increasingly essential.
Explore our dedicated B. animalis development services to accelerate your probiotic research. To support your research with readily available resources, Creative Biolabs offers a range of high-quality B. animalis subsp. lactis products as outlined below:
CAT# | Product Name | Product Overview | Size | Price |
---|---|---|---|---|
LBP-003FG | Bifidobacterium animalis subsp. lactis Powder | Freeze-dried B. animalis subsp. lactis powder. | – | Inquiry |
LBP-009FG | Bifidobacterium lactis Powder | Freeze-dried B. lactis powder. | – | Inquiry |
LBST-053FG | Bifidobacterium animalis subsp. lactis; 700541 | Isolated from yogurt. | 200 µg | $1,560.00 |
LBGF-0722-GF64 | Bifidobacterium animalis subsp. lactis 420 | Known for immunoregulatory effects and enhancing intestinal epithelial integrity in mice and early trials. | 200 µg | $1,590.00 |
B. animalis subsp. lactis has been studied for its roles in supporting gut health, immune response, and microbial balance. Research has explored its use in models of colic, IBS, constipation, respiratory conditions, and more, though scientific evidence varies by application context.
Absolutely. It grows efficiently under anaerobic conditions, producing SCFAs such as acetate. It's a preferred strain in in vitro gut simulation systems and batch fermentation assays for metabolic activity profiling.
Yes, genomic analyses indicate that B. animalis subsp. lactis has a stable genome with minimal risk of horizontal gene transfer. It lacks mobile antibiotic resistance genes, supporting its suitability for live biotherapeutic product research.
References
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.